Insys therapeutics, inc. (INSY)
CashFlow / TTM
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Cash flows from operating activities:
Net loss

-227,981

-124,507

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-1,224

-

29,384

51,090

54,476

58,053

47,337

34,211

34,263

36,054

52,728

52,810

47,892

40,377

9,204

-6,633

-17,548

-24,378

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Inventory obsolescence reserve

5,398

3,095

1,353

4,232

4,609

6,186

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

7,602

7,579

7,521

7,400

7,501

7,337

7,220

6,914

6,496

6,249

6,000

5,857

5,643

5,291

4,614

3,850

3,152

2,500

2,188

2,030

1,882

1,788

1,754

1,683

1,658

1,662

0

0

0

Stock-based compensation

11,955

12,016

12,384

14,289

15,193

16,015

17,166

20,797

21,455

21,589

27,086

23,007

22,288

21,882

16,332

15,049

16,553

15,289

13,462

12,122

7,736

6,339

5,005

3,879

3,173

2,761

0

0

0

Deferred income tax benefit

-

-

-

-

-

-23,243

6,826

6,601

9,516

5,636

8,836

5,385

4,557

4,914

2,534

905

1,445

655

0

0

0

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-1,183

-440

0

0

0

-

-

-

-

-

-

-

-

-41

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Impairment on property and equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of notes receivable and other assets due from stockholders

-

26

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash operating lease expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits on stock options and awards

-

-

-

-

-

-

-

-

-

-

0

0

10,648

-

10,817

16,461

19,868

21,449

0

0

0

-

-

-

-

-

-

-

-

Amortization of investment discount

-125

26

290

563

871

1,125

1,379

1,582

1,807

2,029

2,165

2,075

1,806

1,431

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense accrued on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

900

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Interest expense accrued on notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Accretion (re-valuation) of contingent payment obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,114

0

0

0

Accounts receivable, net

-9,424

-8,903

-10,532

-3,905

2,198

859

-10,312

-15,427

-7,350

-26,618

3,124

4,827

-10,954

23,770

3,385

19,492

13,171

7,796

15,283

6,557

13,237

13,224

12,397

5,617

3,509

3,089

0

0

0

Inventories

-1,420

-2,260

-3,087

-2,836

-3,733

-2,251

-4,555

-6,275

-8,865

-7,647

-1,004

167

3,866

3,280

7,933

14,789

19,772

23,571

19,695

16,028

11,228

7,433

3,600

1,040

103

360

0

0

0

Prepaid expenses and other current assets

-11,458

-9,464

5,967

10,684

13,526

14,518

11,914

5,559

2,970

1,721

-1,207

103

-1,455

-1,345

2,555

2,291

3,234

2,967

1,206

2,018

633

365

142

107

-93

73

0

0

0

Accounts payable, accrued expenses and other current and noncurrent liabilities

38,305

15,802

14,573

11,597

9,386

-118

-2,497

-11,251

-8,509

-12,409

8,961

14,016

18,963

50,708

40,095

51,705

55,593

52,813

50,728

32,660

21,293

14,417

3,378

-63

1,191

166

0

0

0

Accrued sales allowances

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued litigation award and settlements

-90,210

-15,868

435

-135,617

-141,207

-137,067

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

30,060

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued litigation award and settlements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-55,245

-55,989

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

44,190

42,448

30,083

24,249

11,653

1,268

-5,426

-13,627

0

0

0

Cash flows from investing activities:
Purchases of investments

42,337

61,726

74,153

95,897

110,952

132,068

138,396

145,203

139,311

115,375

139,916

133,352

150,575

138,470

98,521

74,791

50,228

56,605

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sales of investments

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of investments

-

-

-

-

-

-

0

0

7,460

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of investments

109,391

104,472

100,964

99,450

94,606

98,448

95,989

108,035

105,947

96,009

86,293

59,426

49,205

36,643

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

5,350

6,095

7,037

9,538

15,512

16,661

16,863

15,126

9,900

10,614

10,448

10,237

11,274

13,842

17,301

21,937

24,421

22,245

18,025

11,309

8,035

5,125

3,050

2,803

797

1,020

0

0

0

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-35,804

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

71,571

53,398

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-59,345

-40,473

-25,281

-5,525

-3,850

-2,803

-797

-1,020

0

0

0

Cash flows from financing activities:
Net repayments on line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,508

-10,317

6,684

11,858

0

0

0

Proceeds from notes payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,987

0

0

0

Excess tax benefits on stock options and awards

-

-

-

-

-

-

-

-

-

-

0

0

10,648

-

10,817

16,461

19,868

21,449

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

590

1,096

2,027

3,130

4,415

4,545

3,878

4,011

3,147

3,803

5,637

5,536

7,704

9,524

11,261

11,824

9,543

8,956

7,025

5,314

4,645

2,102

277

174

143

152

0

0

0

Repurchase of common stock

-

-

-

-

-

-

-

-

-

16,099

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

297

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

1,638

2,144

0

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

31,219

22,418

34,522

26,297

22,225

22,313

6,827

14,997

0

0

0

Change in cash and cash equivalents

17,964

-447

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in cash and cash equivalents

-

-

-

-

-

-

-

-

-5,447

-

-451

-4,745

3,746

21,409

46,570

27,896

30,064

12,724

16,064

24,393

39,324

45,021

30,028

20,778

604

350

0

0

0

Supplemental cash flow disclosures:
Cash paid (refunded) for income taxes, net

-13,501

-13,392

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

0

-

-

-

-

15,351

7,140

4,126

2,975

2,975

3,181

3,190

991

991

0

0

0

-

-

-

-

Non-cash capital expenditures

-557

323

1,328

3,210

865

2,678

3,020

997

2,987

425

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-